S&CO Inc’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-8,150
| Closed | -$591K | – | 195 |
|
|
2021
Q4 | $591K | Hold |
8,150
| – | – | 0.04% | 152 |
|
|
2021
Q3 | $569K | Hold |
8,150
| – | – | 0.04% | 153 |
|
|
2021
Q2 | $561K | Buy |
8,150
+700
| +9% | +$46.7K | 0.04% | 152 |
|
|
2021
Q1 | $481K | Buy |
7,450
+900
| +14% | +$58K | 0.04% | 151 |
|
|
2020
Q4 | $382K | Hold |
6,550
| – | – | 0.03% | 154 |
|
|
2020
Q3 | $414K | Hold |
6,550
| – | – | 0.04% | 148 |
|
|
2020
Q2 | $504K | Sell |
6,550
-590
| -8% | -$45.2K | 0.06% | 134 |
|
|
2020
Q1 | $534K | Buy |
7,140
+90
| +1% | +$6.22K | 0.07% | 119 |
|
|
2019
Q4 | $458K | Buy |
7,050
+100
| +1% | +$6.51K | 0.05% | 150 |
|
|
2019
Q3 | $440K | Buy |
6,950
+325
| +5% | +$21.2K | 0.05% | 150 |
|
|
2019
Q2 | $448K | Buy |
6,625
+235
| +4% | +$15.5K | 0.05% | 151 |
|
|
2019
Q1 | $415K | Buy |
6,390
+65
| +1% | +$4.32K | 0.05% | 155 |
|
|
2018
Q4 | $396K | Buy |
6,325
+330
| +6% | +$23.1K | 0.05% | 149 |
|
|
2018
Q3 | $463K | Sell |
5,995
-175
| -3% | -$13.2K | 0.05% | 147 |
|
|
2018
Q2 | $437K | Sell |
6,170
-1,599
| -21% | -$113K | 0.05% | 151 |
|
|
2018
Q1 | $586K | Buy |
7,769
+1,960
| +34% | +$156K | 0.07% | 126 |
|
|
2017
Q4 | $416K | Sell |
5,809
-579
| -9% | -$44K | 0.05% | 144 |
|
|
2017
Q3 | $518K | Buy |
6,388
+113
| +2% | +$8.64K | 0.07% | 124 |
|
|
2017
Q2 | $444K | Hold |
6,275
| – | – | 0.06% | 134 |
|
|
2017
Q1 | $426K | Buy |
6,275
+95
| +2% | +$6.68K | 0.06% | 130 |
|
|
2016
Q4 | $443K | Sell |
6,180
-9,328
| -60% | -$693K | 0.06% | 126 |
|
|
2016
Q3 | $1.23M | Hold |
15,508
| – | – | 0.18% | 88 |
|
|
2016
Q2 | $1.29M | Buy |
15,508
+990
| +7% | +$87.9K | 0.2% | 81 |
|
|
2016
Q1 | $1.33M | Buy |
14,518
+923
| +7% | +$83.2K | 0.22% | 75 |
|
|
2015
Q4 | $1.38M | Buy |
13,595
+930
| +7% | +$96.8K | 0.23% | 71 |
|
|
2015
Q3 | $1.24M | Buy |
12,665
+900
| +8% | +$100K | 0.21% | 75 |
|
|
2015
Q2 | $1.38M | Buy |
11,765
+1,045
| +10% | +$114K | 0.2% | 77 |
|
|
2015
Q1 | $1.05M | Buy |
10,720
+1,960
| +22% | +$199K | 0.15% | 88 |
|
|
2014
Q4 | $826K | Hold |
8,760
| – | – | 0.12% | 97 |
|
|
2014
Q3 | $933K | Hold |
8,760
| – | – | 0.14% | 85 |
|
|
2014
Q2 | $726K | Hold |
8,760
| – | – | 0.1% | 93 |
|
|
2014
Q1 | $621K | Hold |
8,760
| – | – | 0.09% | 94 |
|
|
2013
Q4 | $658K | Hold |
8,760
| – | – | 0.11% | 86 |
|
|
2013
Q3 | $551K | Hold |
8,760
| – | – | 0.1% | 93 |
|
|
2013
Q2 | $449K | Buy |
+8,760
| New | +$457K | 0.07% | 93 |
|
Other funds holding GILD
S&CO Inc's GILD Position: Q1 2022 in Review
S&CO Inc sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 8,150 shares — an estimated $591K sold.
S&CO Inc first reported a position in GILD in Q2 2013 and held it in 35 quarters. The position peaked at $1.38M in Q2 2015. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- S&CO Inc reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
- S&CO Inc sold 8,150 Gilead Sciences shares in Q1 2022, an estimated $591K.
- S&CO Inc first reported a position in Gilead Sciences in Q2 2013 and held it in 35 quarters.
- S&CO Inc's Gilead Sciences position peaked at $1.38M in Q2 2015.
- 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on S&CO Inc's 13F filing for Q1 2022, filed 5 May 2022.